Thyroid Autoimmunity and Associated Ophthalmopathy

Autoimmune thyroid disorders encompass a spectrum of conditions in which the body’s own immune system targets thyroid antigens, leading to either hyperthyroidism, as in Graves’ disease, or hypothyroidism, as in Hashimoto’s thyroiditis. In many patients with Graves’ disease, autoantibodies directed against the thyrotropin receptor stimulate excessive thyroid hormone production and also drive orbital inflammation in what is commonly known as Graves’ ophthalmopathy or thyroid eye disease. This ophthalmopathy is characterised by activation of orbital fibroblasts, expansion of adipose and connective tissues behind the eye, deposition of glycosaminoglycans and infiltration by immune cells, resulting in eyelid retraction, bulging of the eyes (proptosis), double vision and, in severe cases, optic nerve compression. The interplay of genetic susceptibility, environmental factors such as smoking and iodine intake, and dysregulation of T and B lymphocyte subsets underpins both thyroid autoimmunity and its ocular manifestations. Advances in immunological profiling and imaging have begun to unravel the cellular networks and molecular signals that govern disease onset, progression and remission, offering pathways for more precise diagnosis, risk stratification and targeted therapy.

Research from Nature Portfolio

Recent spatial transcriptomic studies have delineated the complex microenvironment of autoimmune thyroid tissues, revealing previously unrecognised subpopulations of epithelial and stromal cells that shape disease. In affected glands, antigen‐presenting thyroid follicular cells exhibit upregulation of key immune‐modulating mediators, while two distinct fibroblast lineages—one myofibroblastic and enriched in Graves’ disease, the other proinflammatory and associated with Hashimoto’s thyroiditis—have been identified in perithyroidal connective tissue. Accompanying vascular remodelling marked by fenestrated endothelial structures suggests that tissue perfusion and immune cell trafficking are integral to disease propagation. These findings offer a refined cellular atlas for autoimmune thyroiditis and highlight novel molecular targets for intervention.

Thyroid Autoimmunity and Associated Ophthalmopathy publication trend

The graph below shows the total number of articles in thyroid autoimmunity and associated ophthalmopathy across all publications each year (not limited to Nature Index journals).

Technical terms

Thyrotropin receptor antibodies (TSH-R-Abs): Autoantibodies that bind to and activate the thyroid-stimulating hormone receptor, driving hormone overproduction and orbital tissue inflammation.

Spatial transcriptomics: A technique that maps gene expression within intact tissue sections, allowing identification of discrete cellular subpopulations and their local interactions.

Orbital fibroblasts: Connective-tissue cells in the eye socket that can differentiate into fat or myofibroblasts under autoimmune stimulation, contributing to tissue expansion.

Proptosis: Forward displacement of the eyeball, often resulting from increased orbital tissue volume in ophthalmopathy.

Glycosaminoglycans: Water-retaining polysaccharide molecules deposited in orbital connective tissues, causing swelling and stiffness.

References

1. Unraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution. Nature Communications (2024).
2. The insular cortex is not insular in thyroid eye disease: neuroimaging revelations of central–peripheral system interaction. Journal of Neuroinflammation (2024).
3. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Frontiers in Endocrinology (2020).
4. Management of Graves Thyroidal and Extrathyroidal Disease: An Update. The Journal of Clinical Endocrinology & Metabolism (2020).